Oral bioavailability of hyperforin from hypericum extracts in rats and human volunteers.
about
St. John's wort induces hepatic drug metabolism through activation of the pregnane X receptorIn vivo activity and pharmacokinetics of nemorosone on pancreatic cancer xenograftsPharmacokinetic interactions of drugs with St John's wort.Hypericum perforatum extracts as potential antidepressants.Hypericum perforatum (St John's Wort): a non-selective reuptake inhibitor? A review of the recent advances in its pharmacology.St John's wort (Hypericum perforatum L.): a review of its chemistry, pharmacology and clinical properties.Herbal modulation of P-glycoprotein.Hypericum perforatum: pharmacokinetic, mechanism of action, tolerability, and clinical drug-drug interactions.Reduced Alzheimer's disease pathology by St. John's Wort treatment is independent of hyperforin and facilitated by ABCC1 and microglia activation in mice.Hyperforin, a new lead compound against the progression of cancer and leukemia?Pharmacokinetic interactions between herbal remedies and medicinal drugs.Monoamine oxidase A inhibitor occupancy during treatment of major depressive episodes with moclobemide or St. John's wort: an [11C]-harmine PET study.Undeclared exposure to St. John's Wort in hospitalized patientsQuality control of Hypericum perforatum L. analytical challenges and recent progress.The recovery time-course of CYP3A after induction by St John's wort administration.Evidence for contributions of interactions of constituents to the anti-inflammatory activity of Hypericum perforatum.Amended safety assessment of Hypericum perforatum-derived ingredients as used in cosmetics.Hyperforin, an Anti-Inflammatory Constituent from St. John's Wort, Inhibits Microsomal Prostaglandin E(2) Synthase-1 and Suppresses Prostaglandin E(2) Formation in vivo.Brain neurotransmitter receptor binding and nootropic studies on Indian Hypericum perforatum Linn.Comparison of the growth-inhibitory effect of Hypericum perforatum L. extracts, differing in the concentration of phloroglucinols and flavonoids, on leukaemia cells.Effect of St. John's wort on the pharmacokinetics of theophylline in healthy volunteers.Comparison of the synaptosomal uptake inhibition of serotonin by St John's wort products.Effects of oral administration of extracts of Hypericum perforatum (St John's wort) on brain serotonin transporter, serotonin uptake and behaviour in mice.Hypericum Perforatum Hydroalcoholic Extract Mitigates Motor Dysfunction and is Neuroprotective in Intrastriatal 6-Hydroxydopamine Rat Model of Parkinson's Disease.Reduced TRPC6 mRNA levels in the blood cells of patients with Alzheimer's disease and mild cognitive impairment.
P2860
Q24681068-F56D9087-69AD-46FD-A565-58EE56DB944FQ27306776-436ACED5-4F16-4F0C-AB93-EB653496D81EQ33204911-35E7FA19-CEC4-4B36-B5C9-C1F23155C443Q33690247-F84A673F-03EA-4B89-9312-3DD5A40F27B6Q33940268-54F15DFD-B8F0-4E18-B993-484F62157522Q34259736-A88D3FE4-2746-4770-9DFB-C6D7CFE18436Q34312035-97317029-A39E-42CD-8B8A-69A9C3CDBA0CQ34360600-261E9B72-3883-44A4-8123-EE920D211260Q34380018-BBAD2F81-F901-4222-8255-0765DA4F7B96Q34540807-05C58B39-F6AF-4363-81B2-F2101185BDEEQ34771873-403FD453-73B0-4FD1-B765-72E9FC2CE8C0Q35448551-D3F65976-82AE-4EE3-870A-45F706031355Q35826380-170988F9-D190-4227-A41D-6C77A70113C2Q36299085-AFC7AD3D-C1EE-486D-9A10-8A81CA41BEE6Q36729151-78EE366B-44A1-47F6-8F5F-50181EDC022BQ38171858-0CD92354-B44F-40C4-8CF2-58F0CBC72C55Q38258277-0C7A64DC-BDDD-4771-A318-56EEA755773CQ41846509-04DE7E49-849E-491C-839A-685BA61F6CA1Q44091197-52E09D19-D648-459A-AF8D-316A4E2E928DQ44541634-C7046765-08F6-4039-A3A5-F80B4D9A9515Q44697443-5E4BD468-39EF-4438-B44F-B5D776279391Q44961529-3811385C-64BA-473B-9EE9-E2EB4B14E89BQ45162732-5235BFFB-F35F-4AB5-A359-6766E5B10ADFQ48079319-13F581B0-A07B-409A-A061-07E962A41A82Q48145375-24F25CFB-51B1-46E6-81A7-341680B931FD
P2860
Oral bioavailability of hyperforin from hypericum extracts in rats and human volunteers.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
Oral bioavailability of hyperforin from hypericum extracts in rats and human volunteers.
@en
Oral bioavailability of hyperforin from hypericum extracts in rats and human volunteers.
@nl
type
label
Oral bioavailability of hyperforin from hypericum extracts in rats and human volunteers.
@en
Oral bioavailability of hyperforin from hypericum extracts in rats and human volunteers.
@nl
prefLabel
Oral bioavailability of hyperforin from hypericum extracts in rats and human volunteers.
@en
Oral bioavailability of hyperforin from hypericum extracts in rats and human volunteers.
@nl
P2093
P356
P1433
P1476
Oral bioavailability of hyperforin from hypericum extracts in rats and human volunteers.
@en
P2093
P356
10.1055/S-2007-979344
P478
31 Suppl 1
P577
1998-06-01T00:00:00Z